Predict your next investment

GE Healthcare company logo
Corporation
HEALTHCARE | Medical Devices & Equipment
gehealthcare.com

See what CB Insights has to offer

Investments

37

Partners & Customers

10

About GE Healthcare

GE Healthcare has knowledge in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies. The company aims to help physicians develop new ways to predict, diagnose, inform, and treat disease.

GE Healthcare Headquarter Location

100 Results Way

Marlborough, Massachusetts, 01752,

United States

+1 800 526 3593

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing GE Healthcare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find GE Healthcare in 5 Expert Collections, including Health IT .

H

Health IT

3,009 items

C

Conference Exhibitors

5,302 items

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

M

Medical Devices

3,993 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

581 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

GE Healthcare Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

GE Healthcare Rank

Research containing GE Healthcare

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned GE Healthcare in 2 CB Insights research briefs, most recently on Feb 14, 2022.

Latest GE Healthcare News

Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances

Jul 5, 2022

News provided by Share this article Share this article Seasoned health technology executive Lakshmi Gudapakkam to become CEO and former HCA Healthcare, Inc. executive Dr Rick Abramson appointed as Chief Medical Officer. New leadership team to drive expansion of world's first comprehensive AI radiology platform globally and entry into the US. CADt FDA approvals for Annalise Enterprise CXR to bring new opportunities for US clinicians. SYDNEY, July 5, 2022 /PRNewswire/ -- annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer. With the new appointments, annalise.ai expects to further accelerate its global market presence and entry into the US market following recent FDA approvals for part of its comprehensive radiology AI product. With a mission to help one million patients every day, annalise.ai combines cutting-edge AI with clinical expertise to bring comprehensive AI products to market quickly, with state-of-the-art performance and a focus on clinical success. Formed in 2019 as a joint venture between healthcare AI platform harrison.ai and I-MED Radiology Network, Australia's largest diagnostic imaging network, the company is focused on rapidly developing and commercialising comprehensive AI products to advance patient care. annalise.ai products have been used to help more than one million patients since launch. Annalise Enterprise CXR, the world's first comprehensive decision-support AI solution for chest X-rays, is already in clinical use at over 400 sites in Australia and the UK and accessible by one in four Australian radiologists. A recent peer-reviewed diagnostic accuracy study published in The Lancet Digital Health  found Annalise Enterprise CXR improved radiologists' diagnostic accuracy across 102 chest X-ray (CXR) findings*. The company has clearance for clinical use for Annalise Enterprise CXR in Australia, the United Kingdom, Europe, South-East Asia, and New Zealand, and is expanding its products to new geographies. Earlier this year, Annalise Enterprise CXR received CADt FDA clearance for use in triage and notification of pneumothorax and tension pneumothorax on chest X-rays. The appointment of Lakshmi Gudapakkam as CEO will help accelerate expansion plans globally and into the US along with the development of new AI radiology tools. Mr Gudapakkam brings a wealth of healthtech expertise, serving in senior global technology and business leadership roles for more than 20 years in GE Healthcare & Philips Healthcare and for the last four years with Quest Diagnostics, as their Vice President and General Manager for their East Region. During his time with GE Healthcare, Mr Gudapakkam led large global teams across US, Canada, Europe, India, China and Australia in large, breakthrough product development for radiology imaging, cardiology imaging and healthcare informatics. At Philips Healthcare, he oversaw breakthrough products in CT & Advanced Visualization Imaging. Later, Mr Gudapakkam moved into global business leadership roles, building up the Philips Healthcare footprint across China, India and rest of Asia. Mr Gudapakkam led large global businesses including the Global Value Segment business, Global X-ray & Mammography business and later a portfolio of global businesses including CT, Molecular Imaging, X-ray & Mammography. During his time at Quest Diagnostics, Mr Gudapakkam oversaw expansion of the company's diagnostic services through lab management partnerships, managing the scaling of the testing through the COVID pandemic period while leading major transformational programs including standardising IT systems and building out a mega lab in Clifton, New Jersey and consolidating lab testing in the East region. Across his career, Mr Gudapakkam has dealt closely with both technologists and clinical experts in radiology and imaging, providing a broad network and the perfect mix of skills and business acumen to help translate complex technologies into specialist healthcare. Strengthening its global leadership bench even further, Rick Abramson, MD, MHCDS, FACR, joins the annalise.ai team as CMO and will be responsible for guiding the company's clinical roadmap for international expansion. A US-based physician leader and board-certified radiologist, Dr Abramson brings more than 25 years of experience in healthcare including prior roles in clinical practice, academic research, policy development, and management. Previously corporate vice-president over the radiology service line at HCA Healthcare, Inc., Dr Abramson led enterprise strategic development for radiology and artificial intelligence across HCA's network of 185 hospitals in the US and the UK. In his new role with annalise.ai, Dr Abramson will help advance stakeholder partnerships with healthcare providers, technology developers and regulatory bodies across the world. Both Mr Gudapakkam and Dr Abramson will be based in the United States, supported by a strong global team of several hundred annalise.ai staff across Australia, the UK, Europe and now US with expected growth in other locations aligned with projected business growth. Having played an integral role in the formation and success of the joint venture, annalise.ai Founding CEO Dimitry Tran will continue to serve as Director of the Board and part of the harrison.ai team. Dr Aengus Tran, Co-Founder and CEO of harrison.ai, will also continue as annalise.ai's Chief AI Officer. Dimitry Tran, Founding CEO and Board Director of annalise.ai, said: "We set out nearly three years ago to create a cutting-edge AI solution that empowers clinicians to make faster, more accurate decisions on radiology diagnosis. With the hard work of our global team, we've built an extremely strong and sustainable business with a proven model and global roadmap. To truly achieve our goals, and grow globally, we must move into the next phase of our maturity and strategy. I'm excited to welcome Mr Gudapakkam and Dr Abramson to the annalise.ai team to lead the company through this next phase of expansion and to help deliver on our mission to help one million people every day." Clare Battellino, Chair of annalise.ai, said: "Lakshmi is an exceptional executive and someone we are thrilled to have to help drive annalise.ai's vision and strategy forward into our next phase of growth as a company. His approach to innovation, deep expertise in the healthtech space and established network will help to catapult annalise.ai into the future. Dimitry's contribution to annalise.ai cannot be overstated, having tirelessly shepherded the formation and growth of annalise.ai from the beginning. We're delighted that he will continue to have crucial input in the future of annalise.ai as a director of the Board." Dr Aengus Tran, Co-Founder and CEO of harrison.ai, said: "Leveraging harrison.ai's AI capability and its leading clinical partners I-MED, annalise.ai has gone from strength to strength in taking its breakthrough radiology AI products to market. Having achieved sustainable momentum, annalise.ai is on track to help create a more equitable healthcare system for everyone. Lakshmi is well-positioned to help us achieve those goals and will ensure we have the right skills and global connections to expand our reach into new countries, new regulatory areas and new radiology products." Lakshmi Gudapakkam, Chief Executive Officer of annalise.ai, said: "To meet the growing demands on our global healthcare system, we need smart tools that help specialists diagnose and treat patients more effectively and accurately. The team at annalise.ai have shown an astounding ability to not only provide this capability quickly, but do so with clinical experts and patients at the forefront. I'm excited to join the team and contribute to achieving our goal of helping one million patients every day." *Study quote: Assisted radiologist performance -- The deep-learning model statistically significantly improved the classification accuracy of radiologists for 102 (80%) of 127 clinical findings, was statistically non-inferior for 19 (15%) findings, and no findings showed a  decrease in accuracy when radiologists used the deep-learning model. Unassisted radiologists had a macroaveraged mean AUC of 0·713 (0·645–0·785) across all findings, compared with 0·957 (0·954–0·959) for the model alone. SOURCE annalise.ai

GE Healthcare Investments

37 Investments

GE Healthcare has made 37 investments. Their latest investment was in Pulsenmore as part of their PIPE on May 5, 2022.

CBI Logo

GE Healthcare Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/13/2022

PIPE

Pulsenmore

$50M

Yes

6

6/28/2021

Series D

CMR Surgical

$600M

No

31

12/3/2019

Series B

Decisio Health

$11.71M

Yes

3

9/17/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

10/1/2018

Corporate Minority

Subscribe to see more

Subscribe to see more

10

Date

5/13/2022

6/28/2021

12/3/2019

9/17/2019

10/1/2018

Round

PIPE

Series D

Series B

Series C

Corporate Minority

Company

Pulsenmore

CMR Surgical

Decisio Health

Subscribe to see more

Subscribe to see more

Amount

$50M

$600M

$11.71M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

31

3

10

10

GE Healthcare Acquisitions

32 Acquisitions

GE Healthcare acquired 32 companies. Their latest acquisition was Prismatic Sensors on November 20, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/20/2020

Grant

$99M

Acquired

3

11/28/2017

Grant

$99M

$4.88M

Acquired

1

7/10/2017

$99M

Acquired

2

4/11/2017

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

10

3/15/2017

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

11/20/2020

11/28/2017

7/10/2017

4/11/2017

3/15/2017

Investment Stage

Grant

Grant

Series D

Series D

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$4.88M

$99M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

3

1

2

10

10

GE Healthcare Partners & Customers

10 Partners and customers

GE Healthcare has 10 strategic partners and customers. GE Healthcare recently partnered with SOPHiA Genetics on June 6, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

6/9/2022

Partner

Switzerland

1

6/6/2022

Partner

Switzerland

1

6/1/2022

Partner

United States

2

5/23/2022

Distributor

United States

Subscribe to see more

Subscribe to see more

10

5/23/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

6/9/2022

6/6/2022

6/1/2022

5/23/2022

5/23/2022

Type

Partner

Partner

Partner

Distributor

Partner

Business Partner

Country

Switzerland

Switzerland

United States

United States

United States

News Snippet

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

GE Healthcare Team

152 Team Members

GE Healthcare has 152 team members, including current Founder, Chief Executive Officer, Peter J Arduini.

Name

Work History

Title

Status

Peter J Arduini

Founder, Chief Executive Officer

Current

Agnes Berzsenyi

Chief Executive Officer, President

Current

Catherine Estrampes

GE Capital

Chief Executive Officer, President

Current

Kevin O Neill

Chief Executive Officer

Current

Raja V

Chief Executive Officer, President

Current

Name

Peter J Arduini

Agnes Berzsenyi

Catherine Estrampes

Kevin O Neill

Raja V

Work History

GE Capital

Title

Founder, Chief Executive Officer

Chief Executive Officer, President

Chief Executive Officer, President

Chief Executive Officer

Chief Executive Officer, President

Status

Current

Current

Current

Current

Current

You May Also Like

Carestream Health Logo
Carestream Health

Carestream is a worldwide provider of dental and medical imaging systems and IT solutions; X-ray imaging systems for non-destructive testing and advanced materials for the precision films and electronics markets.

Blusense Diagnostics Logo
Blusense Diagnostics

Blusense Diagnostics provides affordable and accurate blood testing for flaviviruses diagnostics.

Happitech Logo
Happitech

Happitech develops a CE Certified heart rhythm SDK for Android & iOS. Once integrated into an application, the company's algorithms allow medical-grade vital signs monitoring directly through a smartphone.

Fujifilm Logo
Fujifilm

Fujifilm manufactures, markets, and provides service for a broad spectrum of industries including photographic, medical imaging and informatics, pharmaceutical, regenerative medicine, and biopharmaceutical contract manufacturing. It is based in Valhalla, New York.

Novarad Logo
Novarad

Novarad is a medical device company. The company develops Novapacs and other diagnostic devices.

S
Sanolla

Sanolla's infrasound-enabling technology is designed for diagnostic medicine. The digital technology platform enables AI-powered detection and interpretation of previously inaccessible body infrasounds, enhancing smart medical diagnosis anywhere, anytime, by anyone.With Sanolla's products, anyone can easily monitor and assess different cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, and COVID-19, with an accuracy level as high as 90%.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.